文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

抗合成酶综合征合并重度ARDS的VV-ECMO治疗及诊断分析一例

[VV-ECMO therapy and diagnostic analysis of a patient with anti-synthetase syndrome complicated by severe acute respiratory distress syndrome].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2026-01-01
一句话结论ASS合并重度ARDS早期易误诊,抗Jo-1抗体检测和多学科会诊是确诊关键,早期VV-ECMO联合俯卧位通气及规范免疫调节可改善预后。

本文报告一例71岁女性抗合成酶综合征(ASS)合并重度急性呼吸窘迫综合征(ARDS)的病例。患者有25天厌食胸闷病史,有冠心病史,入院后肺部感染进展为重度ARDS,机械通气和俯卧位通气下仍存在难治性低氧血症,需VV-ECMO支持。免疫学检测示抗Jo-1抗体708.43 kU/L、抗Ro-52抗体281.82 kU/L,多学科会诊确诊ASS相关重度间质性肺炎合并重度ARDS。治疗采用大剂量糖皮质激素、环磷酰胺免疫抑制及血浆置换,联合VV-ECMO、每日俯卧位通气≥16小时和肺保护性机械通气。患者12天后成功脱离ECMO,拔管后肺部病变逐渐吸收,一个月随访恢复良好。

要点

  • ASS合并重度ARDS早期常被误诊,抗Jo-1抗体检测和多学科会诊是确诊关键。
  • 机械通气及俯卧位通气下仍存在难治性低氧血症时,需考虑VV-ECMO支持。
  • 免疫调节治疗包括大剂量糖皮质激素、环磷酰胺及血浆置换。
  • VV-ECMO期间联合每日俯卧位通气≥16小时和肺保护性机械通气。
  • 本例VV-ECMO支持12天后成功脱机,拔管后肺部病变逐渐吸收,一个月随访恢复良好。

适用人群与场景

  • 抗合成酶综合征(ASS)合并重度ARDS、机械通气及俯卧位通气下仍存在难治性低氧血症的成人患者。
  • 本例为71岁女性,有冠心病史,因厌食、胸闷25天加重1周入院。

诊断标准与关键阈值

  • ASS诊断依据:抗Jo-1抗体708.43 kU/L、抗Ro-52抗体281.82 kU/L,结合多学科会诊。
  • 重度ARDS诊断标准原文未详细列出具体阈值。

处置流程与药物剂量

  • 第一步:机械通气及俯卧位通气,但难治性低氧血症持续时启动VV-ECMO支持。
  • 第二步:免疫调节治疗,包括大剂量糖皮质激素、环磷酰胺为基础的免疫抑制治疗及血浆置换。
  • 第三步:VV-ECMO支持联合每日俯卧位通气≥16小时和肺保护性机械通气。
  • 药物具体剂量、途径、频次及目标值原文未提及。

红旗征与不能漏的情况

  • 机械通气及俯卧位通气下仍存在难治性低氧血症,需及时考虑VV-ECMO支持。
  • ASS合并重度ARDS早期易误诊,需警惕。

研究设计与关键结果

  • 本例为个案报道:71岁女性ASS合并重度ARDS,经VV-ECMO支持12天后成功脱机,拔管后肺部病变逐渐吸收,一个月随访恢复良好。

证据类型、等级与局限

  • 证据类型:个案报道(病例报告)。
  • 局限性:单例个案,无法推广至普遍人群;原文未提及证据等级。

对床旁实践的改变

  • 对ASS合并重度ARDS患者,早期检测抗Jo-1抗体及多学科会诊有助于确诊。
  • 机械通气及俯卧位通气下仍难治性低氧血症时,可考虑早期启动VV-ECMO。
  • 免疫调节治疗(大剂量糖皮质激素、环磷酰胺、血浆置换)联合VV-ECMO和俯卧位通气可能改善预后。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

Anti-synthetase syndrome (ASS) is a rare autoimmune disorder, and cases complicated by severe acute respiratory distress syndrome (ARDS) requiring veno-venous extracorporeal membrane oxygenation (VV-ECMO) are exceedingly uncommon and clinically challenging. On July 6, 2025, a 71-year-old woman with ASS complicated by severe ARDS was admitted to the department of intensive care unit of Huanggang Central Hospital Affiliated to Yangtze University. She presented with a 25-day history of anorexia and chest tightness, which had worsened over the preceding week, and had a known history of coronary artery disease. Following admission, pulmonary infection progressed to severe ARDS. Despite mechanical ventilation and prone positioning, refractory hypoxemia persisted, necessitating VV-ECMO support. Immunological testing revealed markedly elevated anti-Jo-1 antibodies (708.43 kU/L) and anti-Ro-52 antibodies (281.82 kU/L). Multidisciplinary consultation confirmed the diagnosis of ASS-related severe interstitial pneumonia complicated by severe ARDS. The therapeutic strategy included high-dose corticosteroids, cyclophosphamide-based immunosuppressive therapy, and plasma exchange for immune modulation, combined with VV-ECMO support, daily prone positioning for ≥16 hours, and lung-protective mechanical ventilation. The patient's condition gradually improved, and she was successfully weaned from ECMO after 12 days. Following extubation, pulmonary lesions progressively resolved, and favorable recovery was observed at one-month follow-up. This case underscores that ASS complicated by severe ARDS is frequently misdiagnosed in the early stage; detection of anti-Jo-1 antibodies and multidisciplinary consultation are crucial for accurate diagnosis. Early initiation of VV-ECMO combined with prone ventilation effectively improves oxygenation, while standardized immunomodulatory therapy significantly enhances clinical outcomes.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Xu H, Liu X, Qiu C, et al. [VV-ECMO therapy and diagnostic analysis of a patient with anti-synthetase syndrome complicated by severe acute respiratory distress syndrome]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 42693974. doi:10.3760/cma.j.cn121430-20260213-00091

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。